Role of DGCR8 in mammalian pluripotency and innate immunity
dc.contributor.advisor
Macias Ribela, Sara
dc.contributor.advisor
Witteveldt, Jeroen
dc.contributor.advisor
Jose, Garcia-Perez
dc.contributor.author
Knol, Lisanne Iris
dc.contributor.sponsor
Medical Research Council (MRC)
en
dc.date.accessioned
2022-12-05T12:10:11Z
dc.date.available
2022-12-05T12:10:11Z
dc.date.issued
2022-12-05
dc.description.abstract
DGCR8 is an RNA-binding protein involved in canonical micro (mi)RNA biogenesis as
part of the nuclear microprocessor complex. While absence of DGCR8 in mammals
is lethal, DGCR8 hemizygosity is observed in 22q11.2 deletion syndrome
(22q11.2DS), the most frequently observed microdeletion in humans. 22q11.2DS is
associated with aberrant immunity, neuropsychiatric disorders, and a range of
developmental defects.
To better understand the role of DGCR8 in immunity and development, CRISPR-Cas
was used to create DGCR8 knockout and heterozygous PA-1 pluripotent cell lines.
Different types of RNA sequencing revealed an altered transcriptomic landscape. As
expected, DGCR8 knockout cells showed an overall decrease in mature miRNAs
compared to wildtype levels, suggested to be caused by impaired primary miRNA
processing. On the other hand, only a fraction of miRNAs in DGCR8 heterozygotes
was differentially expressed. Notably, miRNAs in the miR-105/767 cluster were
among the most downregulated among both knockout and heterozygote DGCR8
mutant cell lines. Pathway enrichment analysis for differently expressed transcripts
suggested a defect in pluripotency in DGCR8 heterozygote cells, indicating that
DGCR8 hemizygosity could have a more profound contribution to the
developmental symptoms detected in 22q11.2 DS than previously anticipated.
Lastly, we investigated the role of DGCR8 in antiviral immunity during pluripotency.
While embryonic stem cells normally are unable to produce type-I interferons,
Dgcr8-deficient mouse embryonic stem cells can mount an active interferon
response when stimulated via the cytosolic RIG-I-like receptor pathway. This effect
was contributed to the central role of mmu-miR-673 in suppressing the expression
of Mitochondrial Antiviral Signalling Protein, leading to increased susceptibility to
viral infections. These results highlight the importance of miRNAs in modulating
mammalian innate immunity.
en
dc.identifier.uri
https://hdl.handle.net/1842/39557
dc.identifier.uri
http://dx.doi.org/10.7488/era/2807
dc.language.iso
en
en
dc.publisher
The University of Edinburgh
en
dc.subject
MicroRNAs
en
dc.subject
RNA interference
en
dc.subject
MiRNA biogenesis
en
dc.subject
CRISPR-Cas9
en
dc.subject
Poly(I:C) transfections
en
dc.subject
PA-1 DGCR8
en
dc.subject
genome editing
en
dc.subject
Cas9-guideRNA mix
en
dc.subject
RT-qPCR
en
dc.title
Role of DGCR8 in mammalian pluripotency and innate immunity
en
dc.title.alternative
The role of DGCR8 in mammalian pluripotency and innate immunity
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- KnolLI_2022.pdf
- Size:
- 6.73 MB
- Format:
- Adobe Portable Document Format
- Description:
This item appears in the following Collection(s)

